UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$511M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$419M |
| 3 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$353M |
| 4 |
SPDR Gold Trust
GLD
|
+$285M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$258M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.21B |
| 2 |
iShares US Treasury Bond ETF
GOVT
|
+$1.14B |
| 3 |
Microsoft
MSFT
|
+$1.08B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$790M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$401M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.78% |
| 2 | Healthcare | 6.25% |
| 3 | Consumer Discretionary | 6.24% |
| 4 | Financials | 5.99% |
| 5 | Communication Services | 4.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RESP
5426
DELISTED
WisdomTree U.S. ESG Fund
RESP
| $85K | ﹤0.01% |
2,530
-284
| -10% | -$8.91K |
|
|
APHA
5427
DELISTED
Aphria Inc. Common Shares
APHA
| $85K | ﹤0.01% |
19,829
-9,919
| -33% | -$38K |
|
5428
Daktronics
DAKT
$1.03B
| $84K | ﹤0.01% |
19,210
-10,312
| -35% | -$45.6K |
|
|
EH
5429
EHang Holdings
EH
$432M
| $84K | ﹤0.01% |
8,043
+7,562
| +1,572% | +$90.6K |
|
5430
IQ MacKay Municipal Intermediate ETF
MMIT
$1.47B
| $84K | ﹤0.01% |
3,200
+1,405
| +78% | +$36.2K |
|
5431
MediciNova
MNOV
$65M
| $84K | ﹤0.01% |
15,530
-10,937
| -41% | -$58K |
|
|
STR
5432
DELISTED
Sitio Royalties
STR
| $84K | ﹤0.01% |
6,515
-1,562
| -19% | -$16.4K |
|
5433
WBI BullBear Quality 3000 ETF
WBIL
$31M
| $84K | ﹤0.01% |
3,222
-161
| -5% | -$4.15K |
|
|
LJPC
5434
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $84K | ﹤0.01% |
19,845
-6,561
| -25% | -$40K |
|
5435
ACNB Corp
ACNB
$646M
| $83K | ﹤0.01% |
3,187
-1,484
| -32% | -$36.8K |
|
5436
Aptevo Therapeutics
APVO
$5.01M
| – | – |
0
| – | – |
|
5437
Ardelyx
ARDX
$997M
| $83K | ﹤0.01% |
11,987
-18,315
| -60% | -$127K |
|
5438
Dominari Holdings
DOMH
$63.8M
| $83K | ﹤0.01% |
+5,945
| New | +$74.4K |
|
5439
PUT
Eversource Energy
ES
$26.8B
| $83K | ﹤0.01% |
1,000
+100
| +11% | +$8.28K |
|
5440
Keros Therapeutics
KROS
$212M
| $83K | ﹤0.01% |
+2,207
| New | +$68K |
|
|
IMDX
5441
Insight Molecular Diagnostics
IMDX
$154M
| $83K | ﹤0.01% |
2,194
+87
| +4% | +$4.49K |
|
5442
Onto Innovation
ONTO
$14.5B
| $83K | ﹤0.01% |
2,425
-1,349
| -36% | -$43.9K |
|
5443
RBB Bancorp
RBB
$450M
| $83K | ﹤0.01% |
6,100
-4,305
| -41% | -$55.5K |
|
|
HTB
5444
HomeTrust Bancshares
HTB
$826M
| $83K | ﹤0.01% |
5,183
-4,746
| -48% | -$71.4K |
|
|
CONN
5445
DELISTED
Conn's Inc.
CONN
| $83K | ﹤0.01% |
8,258
+2,471
| +43% | +$16.3K |
|
|
WBII
5446
DELISTED
WBI BullBear Global Income ETF
WBII
| $83K | ﹤0.01% |
3,527
-2,525
| -42% | -$59.1K |
|
|
GPAQW
5447
DELISTED
Gordon Pointe Acquisition Corp. Warrant
GPAQW
| $83K | ﹤0.01% |
38,294
+29,297
| +326% | +$19.3K |
|
|
AMNB
5448
DELISTED
American National Bankshares Inc
AMNB
| $83K | ﹤0.01% |
3,322
-2,916
| -47% | -$69.8K |
|
5449
BeyondSpring
BYSI
$32.3M
| $82K | ﹤0.01% |
5,458
-3,068
| -36% | -$46.8K |
|
|
FONR
5450
DELISTED
Fonar
FONR
| $82K | ﹤0.01% |
3,855
+3,815
| +9,538% | +$78K |
|
Similar funds
UBS Group's Q2 2020 Portfolio in Review
As of Q2 2020, UBS Group held 8,813 positions worth $237B, up 12% from $212B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group withdrew a net $17.5B in Q2 2020, closing 776 positions and reducing 4,001 holdings. Its most notable exit was Allergan plc, an estimated $1.21B position sold in full.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, UBS Group opened a new position in Warner Music worth $87.9M.
- UBS Group's largest Q2 2020 buy was Warner Music: 2,981,053 shares worth $87.9M.
- UBS Group added most to Vanguard Morningstar Mid-Cap ETF in Q2 2020, an estimated $511M increase.
- UBS Group's biggest Q2 2020 reduction was iShares US Treasury Bond ETF, cutting an estimated $1.14B.
- UBS Group fully exited Allergan plc in Q2 2020, selling an estimated $1.21B.
- UBS Group's ten largest holdings make up 16% of its $237B portfolio in Q2 2020.
- UBS Group opened 706 new positions and closed 776 in Q2 2020.
- UBS Group's portfolio value rose 12% quarter-over-quarter to $237B.
Based on UBS Group's 13F filing for Q2 2020, filed 31 Jul 2020.